Research progress of Dexamethasone sustained release in the treatment of diabetic macular edema / 国际眼科杂志(Guoji Yanke Zazhi)
International Eye Science
; (12): 1543-1547, 2021.
Article
em Zh
| WPRIM
| ID: wpr-886432
Biblioteca responsável:
WPRO
ABSTRACT
@#Diabetic macular edema(DME)is the foremost cause of vision impairment and even blindness in patients with diabetes mellitus. Nowadays, the approach in the treatment of DME involves laser photocoagulation, intravitreal injections of anti-VEGF agents or triamcinolone acetonide. However, they still have some limitations. In recent years, dexamethasone intravitreal implant, as a new treatment option, has brought therapeutic hope to DME patients who have poor response to other methods. Meanwhile, it has the advantages of good clinical efficacy, long duration, acceptable safety and good patient tolerability. In this paper, the research advances in dexamethasone intravitreal implant for DME are described.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
International Eye Science
Ano de publicação:
2021
Tipo de documento:
Article